[go: up one dir, main page]

FR2886154B1 - Composition pour retarder le developpement de la maladie d'alzheimer - Google Patents

Composition pour retarder le developpement de la maladie d'alzheimer

Info

Publication number
FR2886154B1
FR2886154B1 FR0505365A FR0505365A FR2886154B1 FR 2886154 B1 FR2886154 B1 FR 2886154B1 FR 0505365 A FR0505365 A FR 0505365A FR 0505365 A FR0505365 A FR 0505365A FR 2886154 B1 FR2886154 B1 FR 2886154B1
Authority
FR
France
Prior art keywords
alzheimer
delaying
disease
development
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0505365A
Other languages
English (en)
Other versions
FR2886154A1 (fr
Inventor
Dominique Bourgeade
Jean Christophe Anton
Francois Miceli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COTHERA
Original Assignee
COTHERA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COTHERA filed Critical COTHERA
Priority to FR0505365A priority Critical patent/FR2886154B1/fr
Priority to EP06755300A priority patent/EP1890689A2/fr
Priority to US11/921,066 priority patent/US20090181974A1/en
Priority to PCT/EP2006/062608 priority patent/WO2006125810A2/fr
Publication of FR2886154A1 publication Critical patent/FR2886154A1/fr
Application granted granted Critical
Publication of FR2886154B1 publication Critical patent/FR2886154B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0505365A 2005-05-27 2005-05-27 Composition pour retarder le developpement de la maladie d'alzheimer Expired - Fee Related FR2886154B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR0505365A FR2886154B1 (fr) 2005-05-27 2005-05-27 Composition pour retarder le developpement de la maladie d'alzheimer
EP06755300A EP1890689A2 (fr) 2005-05-27 2006-05-24 Composition pour retarder le développement de la maladie d'alzheimer
US11/921,066 US20090181974A1 (en) 2005-05-27 2006-05-24 Composition for slowing down the development of alzheimer's disease
PCT/EP2006/062608 WO2006125810A2 (fr) 2005-05-27 2006-05-24 Composition pour retarder le développement de la maladie d'alzheimer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0505365A FR2886154B1 (fr) 2005-05-27 2005-05-27 Composition pour retarder le developpement de la maladie d'alzheimer

Publications (2)

Publication Number Publication Date
FR2886154A1 FR2886154A1 (fr) 2006-12-01
FR2886154B1 true FR2886154B1 (fr) 2010-03-26

Family

ID=35466542

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0505365A Expired - Fee Related FR2886154B1 (fr) 2005-05-27 2005-05-27 Composition pour retarder le developpement de la maladie d'alzheimer

Country Status (4)

Country Link
US (1) US20090181974A1 (fr)
EP (1) EP1890689A2 (fr)
FR (1) FR2886154B1 (fr)
WO (1) WO2006125810A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013526865A (ja) * 2010-05-13 2013-06-27 ニトロメガ コーポレーション ニトロ脂肪酸、神経保護および/または認識減退の抑制
WO2016109853A2 (fr) * 2015-01-02 2016-07-07 Melaleuca, Inc. Compositions de compléments alimentaires
TWI759260B (zh) 2015-01-02 2022-04-01 美商梅拉洛伊卡公司 多元補充品組成物
TWI790189B (zh) 2015-01-02 2023-01-21 美商梅拉洛伊卡公司 細菌組成物

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1052637B (de) * 1956-05-03 1959-03-12 Merck Ag E Verfahren zur Herstellung von haltbaren Vitamin-B-Kombinationspraeparaten in Kapselform
SE416374B (sv) * 1974-11-27 1980-12-22 Otc Consult Ab Forfarande for framstellning av fodermedel for fisk
JPS57110176A (en) * 1980-12-27 1982-07-08 Snow Brand Milk Prod Co Ltd Nutrious food composition for tube feeding
JPS58126767A (ja) * 1982-01-22 1983-07-28 Ajinomoto Co Inc 肝臓病患者用栄養組成物
FR2544613B1 (fr) * 1983-04-20 1985-10-25 Roussel Uclaf Nouvelles compositions destinees a etre utilisees en dietetique, en reanimation et en therapeutique, renfermant une fraction proteique a base de trois types de minipeptides
LU87145A1 (fr) * 1988-02-26 1989-09-20 Oreal Methode pour ameliorer l'aspect esthetique de la peau a l'aide de melanges polyvitaminiques
EP0593774B1 (fr) * 1992-04-10 1997-08-06 Otsuka Pharmaceutical Co., Ltd. Composition alimentaire inhibant la formation de produits de putrefaction intestinale
FR2691616B1 (fr) * 1992-05-27 1995-06-09 Thorel Jean Noel Bio-vecteurs nutritionnels.
FR2706255B1 (fr) * 1993-06-17 1995-10-27 Univ Rennes Composition à usage alimentaire et/ou pharmaceutique pauvre en polyamines et applications thérapeutiques.
EP0689834A3 (fr) * 1994-07-01 1996-06-05 Willem Jacob Serfontein Additif alimentaire pour l'homme ou les animaux contenant des vitamines et des sels minéraux à libération prolongée
TW360501B (en) * 1996-06-27 1999-06-11 Nestle Sa Dietetically balanced milk product
EP0920813A1 (fr) * 1997-12-08 1999-06-09 Societe Des Produits Nestle S.A. Accélération de la vitesse de digéstion d'une protéine
US6403142B1 (en) * 1998-12-11 2002-06-11 Ralston Purina Company Hypoallergenic pet food
US6569857B1 (en) * 1999-05-03 2003-05-27 Drugtech Corporation Dietary supplement
US20050037065A1 (en) * 1999-05-27 2005-02-17 Drugtech Corporation Nutritional formulations
US6258846B1 (en) * 1999-06-01 2001-07-10 Drugtech Corporation Nutritional supplements
US7704542B2 (en) * 2001-09-12 2010-04-27 Xanodyne Pharmaceuticals, Inc. Vitamin/mineral compositions with DHA
EP1302115A1 (fr) * 2001-10-16 2003-04-16 Societe Des Produits Nestle S.A. Utilisation de cystathionine
US7445807B2 (en) * 2002-10-15 2008-11-04 Western Holdings, Llc Agglomerated granular protein-rich nutritional supplement
FR2860976B1 (fr) * 2003-10-20 2006-02-10 Ravi Shrivastava Nouvelles compositions synergiques pour ameliorer la biodisponibilite et l'efficacite des acides gras polyinsatures pour le traitement des troubles du fonctionnement cerebral.

Also Published As

Publication number Publication date
EP1890689A2 (fr) 2008-02-27
FR2886154A1 (fr) 2006-12-01
WO2006125810A3 (fr) 2007-05-10
US20090181974A1 (en) 2009-07-16
WO2006125810A2 (fr) 2006-11-30

Similar Documents

Publication Publication Date Title
FR23C1029I1 (fr) Compositions d'anticorps anti-ctla-4
EP1940373B8 (fr) 1-fluoro-1-deoxy-scyllo-inositol destine au traitement de la maladie d'alzheimer
EP1976558A4 (fr) Utilisation d'une composition immunogène de pcv2 pour la réduction de symptômes cliniques
IL188165A0 (en) Method for the diagnosis of alzheimer's disease
DK1847524T3 (da) Terphenylderivater til behandling af Alzheimers sygdom
EP1834573A4 (fr) Section d'insertion pour endoscope
EP1854467A4 (fr) Composition pour l'activation immunitaire
EP1855525A4 (fr) Modeles poisson zebre de la maladie d'alzheimer
EP1736263A4 (fr) Structure d'accrochage pour puce amovible
EP1746141A4 (fr) Composition d' epaississement
EP1797903A4 (fr) Agent de diagnostic pour tumeur
EP1714643A4 (fr) Preparation pour liberation soutenue
EP2379075A4 (fr) Dérivés de triazole pour le traitement de la maladie d'alzheimer
EP1954493A4 (fr) Pellicule anticopie à image
FR2892529B1 (fr) Systeme d'aide pour la correction de la vue
EP2344881A4 (fr) Biomarqueurs pour la maladie d'alzheimer
FR2886154B1 (fr) Composition pour retarder le developpement de la maladie d'alzheimer
FR2879931B1 (fr) Materiau silicone pour la liberation d'une molecule active
GB0414894D0 (en) Biomarkers of alzheimer's disease
EP2062588A4 (fr) Composition pour l'amélioration de l'état de la peau
EP1867337A4 (fr) Composition médicinale pour traiter/prévenir la maladie d'organes moteurs
EP1813596A4 (fr) Procédé de synthèse d'une alpha, alpha-difluoroamine
EP2127658A4 (fr) Agent thérapeutique pour la maladie de ménière
EP1690116A4 (fr) Resolution de limite de sous diffraction en microscopie
FR2891847B1 (fr) Installation pour la preparation d'une composition de couchage

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20120131